Simplify Logo

Full-Time

Sr. Director

Program Management

Posted on 5/22/2024

4D Molecular Therapeutics

4D Molecular Therapeutics

51-200 employees

Develops gene therapies for genetic diseases

Biotechnology
Healthcare

Compensation Overview

$250k - $314kAnnually

Expert

Oakland, CA, USA

Category
Public Health
Biology & Biotech
Requirements
  • Bachelor’s degree in life sciences or a relevant field
  • Advanced degree in life sciences preferred
  • 15+ years’ experience managing global complex cross-functional programs in the biopharmaceutical industry
  • 6 + years of management experience
  • Deep experience managing and leading drug development projects/programs at a pre-clinical and clinical stage within the biopharmaceutical industry
  • Must have sound knowledge of integrated drug development processes in a biopharmaceutical company
  • Experience with gene or cell therapy programs preferred
  • Experience in ophthalmology, cardiology, or pulmonology therapeutic areas is desirable
  • Ability to manage multiple work streams and projects concurrently
  • Ability to problem-solve, research issues, and propose solutions
  • Excellent interpersonal and communication skills, both written and oral, and ability to communicate complex information succinctly
  • Team player who leads by example employs expertise and influence to encourage collaboration across departments, levels, and groups to achieve shared objectives
  • Project Management Professional (PMP) or other relevant certification is a plus
  • Ability to function independently in a fast-paced environment
  • Proficient in the Microsoft suite of programs
  • MS Project SME
  • OnePage
Responsibilities
  • Lead cross functional teams to develop and execute upon clinical program strategy
  • Assess the needs of programs alongside Therapeutic Area Heads and Project Team Leader
  • Drive planning for key drug development stage-gate decision points
  • Identify project risks and proactively facilitate mitigation strategies and resolution
  • Ensure relevant communication and alignment across departments
  • Effectively present information, respond to questions, facilitate communications regarding program risks and business impacts
  • Support to establish, maintain and enforce best practices
  • Support development, implementation and adherence to operational procedures
  • Actively participate in system and process improvements
4D Molecular Therapeutics

4D Molecular Therapeutics

View

4D Molecular Therapeutics develops gene therapies aimed at treating serious genetic diseases by delivering specific genetic material to patients' cells. The company utilizes a unique technology called Therapeutic Vector Evolution to create adeno-associated virus (AAV) vectors, which act as delivery vehicles for therapeutic genes targeting affected cells. Unlike many competitors, 4DMT focuses on precision medicine for genetic disorders, including cystic fibrosis, and emphasizes rigorous research and clinical trials to ensure the safety and effectiveness of its therapies. The company's goal is to commercialize these gene therapies through direct sales or partnerships with larger pharmaceutical firms, while also securing funding to support its development efforts.

Company Stage

IPO

Total Funding

$595M

Headquarters

Emeryville, California

Founded

2013

Growth & Insights
Headcount

6 month growth

19%

1 year growth

36%

2 year growth

59%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful clinical trials, such as the positive interim data from the Phase 1/2 AEROW trial, bolster confidence in 4DMT's therapeutic pipeline.
  • The recent $75 million Series C financing provides substantial capital to advance R&D and clinical programs.
  • The appointment of experienced executives, like Uneek Mehra as Chief Financial and Business Officer, strengthens the company's leadership team.

What critics are saying

  • The biopharmaceutical market is highly competitive, with numerous companies vying to develop similar gene therapies.
  • Regulatory hurdles and clinical trial setbacks, such as the initial clinical hold on 4D-310, can delay product development and commercialization.

What makes 4D Molecular Therapeutics unique

  • 4DMT leverages its proprietary 'Therapeutic Vector Evolution' technology to create advanced AAV vectors, setting it apart from competitors in the gene therapy space.
  • The company's focus on aerosolized genetic medicines, such as 4D-710 for cystic fibrosis, highlights its innovative approach to gene delivery.
  • Strategic partnerships, like the $962M deal with Astellas Pharma, underscore 4DMT's ability to attract significant investment and collaboration opportunities.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE